The 2019 CAS Future Leaders program is now accepting applications!
Solve Scientific Information Challenges
Whether you are trying to advance your research, repurpose existing technology or make strategic investment decisions, CAS can help you get there faster while minimizing risk.
CAS is a global organization of expert scientists, technologists, and business leaders with a successful and extended history of delivering scientific information opportunities.
From our market-leading products, like SciFindern and STN®, to solutions tailored to your specific needs, we are ready to partner with you.
CAS can help
Accelerate Innovation
- Generate new ideas
- Expand your pipeline
- Get to market faster
- Enhance productivity
Manage Information
- Harness the power of big data
- Provide quality content & tools
- Integrate & manage resources
- Enable accessibility
Protect Intellectual Property
- Maximize the value of your portfolio
- Understand the landscape
- Avoid surprises
- Align strategy with opportunity
CAS Products
CAS offers a wide range of solutions designed to meet the needs of research, patent, regulatory, and business professionals in every phase of the innovation process.
CAS Services
With over 100 years’ experience, no one knows more about working with scientific information than CAS. Leverage our expertise to customize solutions for your organization’s unique information challenges.
Being able to rapidly search for important chemical information while an idea is fresh in your mind is almost priceless. CAS databases streamline the investigative process—allowing you to take an idea and rapidly find the important and necessary information before you forget about the idea or it loses its excitement. That really is invaluable.
Dr. Robert H. GrubbsNobel LaureateVictor and Elizabeth Atkins Professor of Chemistry, California Institute of Technology
Contact CAS
Let us know how we can best serve you.
Resources
Whitepapers
Global Science & Technology Trends Report - Therapeutic Fusion Protein R&D
With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.
Read more
Press Releases
Aptean and CAS collaborate to offer CAS Biosequences content in GenomeQuest
Aptean and CAS now offer CAS Biosequences content in GenomeQuest. Combining the CAS Biosequences Module and the GQ-Pat database on a single platform delivers a unique, comprehensive “one-stop” search solution for biotechnology intellectual property.
Read more
Press Releases
Leading Global CRO/CDMO AMRI Commits to 5-year Agreement for SciFinder from CAS to Enable Efficient Research and Client Success
AMRI, a leading global CRO, signs a 5-year Agreement for SciFinder from CAS.
Read more